Literature DB >> 16695345

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION.

J A Luetscher1, H Eagle, W T Longcope, E B Watson.   

Abstract

Entities:  

Year:  1946        PMID: 16695345      PMCID: PMC435591          DOI: 10.1172/JCI101735

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  Chemical constitution and toxicity.

Authors:  E Walker
Journal:  Biochem J       Date:  1928       Impact factor: 3.857

2.  Public Health Weekly Reports for JANUARY 29, 1932.

Authors: 
Journal:  Public Health Rep       Date:  1932-01-29       Impact factor: 2.792

3.  BAL (BRITISH ANTI-LEWISITE).

Authors:  L L Waters; C Stock
Journal:  Science       Date:  1945-12-14       Impact factor: 47.728

4.  ENZYME SYSTEMS CONTAINING ACTIVE SULFHYDRYL GROUPS. THE ROLE OF GLUTATHIONE.

Authors:  E S Barron; T P Singer
Journal:  Science       Date:  1943-04-16       Impact factor: 47.728

5.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL.

Authors:  W T Longcope; J A Luetscher; M M Wintrobe; V Jäger
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

  5 in total
  4 in total

1.  Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.

Authors:  H EAGLE; H J MAGNUSON; R FLEISCHMAN
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

Review 2.  The role of chelation in the treatment of arsenic and mercury poisoning.

Authors:  Michael J Kosnett
Journal:  J Med Toxicol       Date:  2013-12

3.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL.

Authors:  W T Longcope; J A Luetscher; M M Wintrobe; V Jäger
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

4.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE.

Authors:  J Wexler; H Eagle; H J Tatum; H J Magnuson; E B Watson
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.